
The Oncology Institute, Inc. – NASDAQ:TOIIW
The Oncology Institute stock price today
The Oncology Institute stock price monthly change
The Oncology Institute stock price quarterly change
The Oncology Institute stock price yearly change
The Oncology Institute key metrics
Market Cap | 755.59K |
Enterprise value | 99.22M |
P/E | 0.37 |
EV/Sales | 0.26 |
EV/EBITDA | 4.02 |
Price/Sales | 0.01 |
Price/Book | 0.04 |
PEG ratio | -10.10 |
EPS | -0.89 |
Revenue | 342.71M |
EBITDA | -54.55M |
Income | -65.90M |
Revenue Q/Q | 24.24% |
Revenue Y/Y | 25.29% |
Profit margin | 3.66% |
Oper. margin | -32.21% |
Gross margin | 42.89% |
EBIT margin | -32.21% |
EBITDA margin | -15.92% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeThe Oncology Institute stock price history
The Oncology Institute stock forecast
The Oncology Institute financial statements
Jun 2023 | 80.22M | -16.89M | -21.06% |
---|---|---|---|
Sep 2023 | 82.03M | -17.41M | -21.23% |
Dec 2023 | 85.78M | -15.31M | -17.85% |
Mar 2024 | 94.66M | -16.27M | -17.19% |
Jun 2023 | 229959000 | 145.23M | 63.16% |
---|---|---|---|
Sep 2023 | 218353000 | 146.50M | 67.1% |
Dec 2023 | 219418000 | 162.39M | 74.01% |
Mar 2024 | 204532000 | 163.23M | 79.81% |
Jun 2023 | -8.66M | 24.90M | -2.60M |
---|---|---|---|
Sep 2023 | -8.31M | 7.70M | -756K |
Dec 2023 | -3.89M | 11.62M | -1.78M |
Mar 2024 | -15.88M | 19.38M | -938K |
The Oncology Institute alternative data
Aug 2023 | 553 |
---|---|
Sep 2023 | 553 |
Oct 2023 | 553 |
Nov 2023 | 553 |
Dec 2023 | 553 |
Jan 2024 | 553 |
Feb 2024 | 553 |
Mar 2024 | 700 |
Apr 2024 | 800 |
May 2024 | 800 |
Jun 2024 | 800 |
Jul 2024 | 800 |
The Oncology Institute other data
Period | Buy | Sel |
---|---|---|
May 2022 | 0 | 1600000 |
Jun 2022 | 0 | 300000 |
Aug 2022 | 0 | 287582 |
Sep 2022 | 0 | 745627 |
Oct 2022 | 0 | 514269 |
Nov 2022 | 0 | 787686 |
Dec 2022 | 73684 | 0 |
Mar 2023 | 50000 | 0 |
-
What's the price of The Oncology Institute stock today?
One share of The Oncology Institute stock can currently be purchased for approximately $0.13.
-
When is The Oncology Institute's next earnings date?
Unfortunately, The Oncology Institute's (TOIIW) next earnings date is currently unknown.
-
Does The Oncology Institute pay dividends?
No, The Oncology Institute does not pay dividends.
-
How much money does The Oncology Institute make?
The Oncology Institute has a market capitalization of 755.59K and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 28.42% to 324.24M US dollars.
-
What is The Oncology Institute's stock symbol?
The Oncology Institute, Inc. is traded on the NASDAQ under the ticker symbol "TOIIW".
-
What is The Oncology Institute's primary industry?
Company operates in the Healthcare sector and Medical - Care Facilities industry.
-
How do i buy shares of The Oncology Institute?
Shares of The Oncology Institute can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does The Oncology Institute have?
As Jul 2024, The Oncology Institute employs 800 workers.
-
Where are The Oncology Institute's headquarters?
The Oncology Institute is headquartered at 18000 Studebaker Road, Cerritos, CA.
-
How can i contact The Oncology Institute?
The Oncology Institute's mailing address is 18000 Studebaker Road, Cerritos, CA and company can be reached via phone at +213 7601328.
The Oncology Institute company profile:
NASDAQ
800
Medical - Care Facilities
Healthcare
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.
Cerritos, CA 90703
CIK: 0001799191
ISIN: US68236X1182
CUSIP: 68236X118